AT-511 clinical trials
How each study uses AT-511 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2021 (4)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2021 | 4 |
| 2025 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 8 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses AT-511 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or MethadoneCompletedPhase 1Atea Pharmaceuticals, Inc.NCT07314346Written as Buprenorphine/Naloxone + BEM/RZR
- Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Ethinyl Estradiol/Levonorgestrel (EE/LNG)CompletedPhase 1Atea Pharmaceuticals, Inc.NCT07272889Written as Bemnifosbuvir/Ruzasvir (BEM/RZR) + Ethinyl Estradioll/Levonorgestrel (EE/LNG)
- Drug-drug Interaction Study of Omeprazole and Bemnifosbuvir/RuzasvirCompletedPhase 1Atea Pharmaceuticals, Inc.NCT07007806Written as Treatment A-Bemnifosbuvir/Ruzasvir FDC administered fasting
- Study to Evaluate the Effects of RO7496998 (AT-527) in Non-Hospitalized Adult and Adolescent Participants With Mild or Moderate COVID-19TerminatedPhase 3Hoffmann-La RocheNCT04889040Written as RO7496998
- Mass Balance Study of AT-527 in Healthy Adult Male Subjects (R07496998)CompletedPhase 1Atea Pharmaceuticals, Inc.NCT05004415Written as AT-527 (R07496998)
- Study of AT-527 in Healthy Subjects (R07496998)CompletedPhase 1Atea Pharmaceuticals, Inc.NCT04711187Written as AT-527 Formulation 1
- Effect of Carbamazepine on the Pharmacokinetics (PK) of AT-527CompletedPhase 1Atea Pharmaceuticals, Inc.NCT04784000Written as Period 1: AT-527 550 mg
- Drug-drug Interaction Study of Midazolam and AT-527 (R07496998)CompletedPhase 1Atea Pharmaceuticals, Inc.NCT04865445Written as AT-527 550 mg + midazolam